( 2 ) tpa was demonstrated in 65 % of ovarian serous and 75 % of ovarian mucinous cystadenocarcinomas , and in 58 % of endometrial carcinomas .
C0279665
ovarian mucinous cystadenocarcinomas
C0476089
of endometrial carcinomas